Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Pfizer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles E. Triano has been named senior vice president, investor relations, Pfizer, effective June 23. Mr. Triano will be responsible for all investor relations functions, including communicating the financial and operational performance of the company with institutional and retail investors. He will report to chief financial officer Frank D’Amelio.
   
Mr. Triano served as the vice president of investor relations at Forest Laboratories since 2000, where he initiated the company’s first formal investor relations and corporate communications program. Previously, Mr. Triano served as director of investor relations at Bristol-Myers Squibb Co. and as managing director at The Carson Group (acquired by Thomson Financial in 2000).
   
“We are pleased to welcome Chuck to Pfizer,” said Mr. D’Amelio. “As a seasoned investor relations executive who has earned the trust of the investment community and built a highly respected investor relations program, Chuck will be a clear asset to our company. In addition, he brings a deep knowledge of the pharmaceutical industry and its regulatory environment combined with extensive investor relations experience, which will continue to strengthen our relationship with the investment community and our shareholders.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters